Citigroup
BNTX icon

Citigroup’s BioNTech BNTX Stock Holding History

Citigroup’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.5M Buy
359,784
+49,418
+16% +$4.65M 0.01% 910
2026
Q1 		$27.6M Buy
310,366
+54,141
+21% +$5.56M 0.01% 907
2025
Q4 		$24.4M Buy
256,225
+76,592
+43% +$7.72M 0.01% 995
2025
Q3 		$17.7M Buy
179,633
+14,803
+9% +$1.58M 0.01% 1142
2025
Q2 		$17.5M Sell
164,830
-97,154
-37% -$9.81M 0.01% 1037
2025
Q1 		$23.9M Buy
261,984
+245,968
+1,536% +$27.5M 0.01% 869
2024
Q4 		$1.83M Sell
16,016
-44,777
-74% -$5.11M ﹤0.01% 2891
2024
Q3 		$7.22M Sell
60,793
-97,148
-62% -$8.93M ﹤0.01% 1541
2024
Q2 		$12.7M Buy
157,941
+100,974
+177% +$9.23M 0.01% 1127
2024
Q1 		$5.26M Buy
56,967
+1,484
+3% +$142K ﹤0.01% 1679
2023
Q4 		$5.86M Buy
55,483
+9,445
+21% +$952K ﹤0.01% 1484
2023
Q3 		$5M Sell
46,038
-21,141
-31% -$2.34M ﹤0.01% 1432
2023
Q2 		$7.25M Sell
67,179
-5,854
-8% -$658K ﹤0.01% 1285
2023
Q1 		$9.1M Buy
73,033
+17,873
+32% +$2.45M 0.01% 1208
2022
Q4 		$8.29M Sell
55,160
-35,568
-39% -$5.47M 0.01% 1224
2022
Q3 		$12.2M Sell
90,728
-24,286
-21% -$3.71M 0.01% 1051
2022
Q2 		$17.1M Sell
115,014
-6,055
-5% -$925K 0.01% 873
2022
Q1 		$20.6M Sell
121,069
-53,955
-31% -$9.07M 0.01% 931
2021
Q4 		$45.1M Buy
175,024
+25,767
+17% +$7.06M 0.02% 600
2021
Q3 		$40.7M Sell
149,257
-9,075
-6% -$2.88M 0.02% 624
2021
Q2 		$35.4M Buy
158,332
+84,445
+114% +$15.9M 0.02% 683
2021
Q1 		$8.07M Buy
73,887
+38,846
+111% +$4.13M 0.01% 1497
2020
Q4 		$2.86M Buy
35,041
+31,588
+915% +$3.1M ﹤0.01% 2519
2020
Q3 		$239K Buy
3,453
+589
+21% +$42.3K ﹤0.01% 4488
2020
Q2 		$191K Buy
+2,864
New +$143K ﹤0.01% 5044

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Citigroup's BNTX Position: Q2 2026 in Review

Citigroup increased its BioNTech (BNTX) stake by 16% in Q2 2026, buying an estimated $4.65M and bringing the position to 359,784 shares worth $33.5M. The position accounts for 0.01% of the portfolio, ranked #910.

Citigroup first reported a position in BNTX in Q2 2020 and has held it in 25 quarters since. The position peaked at $45.1M in Q4 2021. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Citigroup held 359,784 shares of BioNTech worth $33.5M as of Q2 2026.
  • Citigroup bought 49,418 BioNTech shares in Q2 2026, an estimated $4.65M.
  • BioNTech made up 0.01% of Citigroup's portfolio in Q2 2026, its #910 holding.
  • Citigroup first reported a position in BioNTech in Q2 2020 and has held it in 25 quarters since.
  • Citigroup's BioNTech position peaked at $45.1M in Q4 2021.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.